← Evidence map

ArticleHeliyon2022

An L-theanine derivative targets against SARS-CoV-2 and its Delta and Omicron variants.

Jing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35706933